Guided by our Healthy Lives Mission, Kenvue is dedicated to enhancing global health by supporting people in their journey to quit smoking and vaping. That’s why we’re investing in science, innovation, and partnerships to create a smoke-free future.
Our Nicorette® brand is driving meaningful change by increasing access to effective nicotine replacement therapies (NRTs) and educating consumers about new treatments. In Malaysia, we’ve taken a significant step forward by training healthcare professionals to harness the power of NRTs like Nicorette®—enhancing the country’s ability to support smokers on their quitting journey. We also partnered with the Ministry of Health to launch Cik Era, an AI-powered chatbot that guides smokers and connects them with local support services.
For the second year running, Kenvue has proudly supported the ASEAN Advisory Board for Smoking Cessation, bringing together experts across Asia Pacific. This event has helped address public health concerns, from integrating smoking cessation into tuberculosis treatment services in Indonesia to advancing vaping research in Singapore.
We’re breaking new ground in the fight against vaping with our latest peer-reviewed research in the UK. The study, published in the journal Addiction, showed that Nicorette® QuickMist®, a nicotine mouth spray, can be a game-changer for those looking to quit vaping. This research highlights our dedication to driving positive change in public health through evidence-based solutions.
Kenvue is working to improve the health of communities around the world. By combining science, innovation, and local partnerships, we are helping people everywhere move closer to a healthier, smoke-free future.